Therapeutic use of melatonin in schizophrenia-more than meets the eye!

Adjunctive melatonin use in schizophrenia, as supported by a modicum of evidence, has multiple transcending chronobiotic actions, including fixing concurrent sleep problems to bona fide augmentative antipsychotic actions, mitigating the risk of tardive dyskinesias, curbing the drastic metabolic synd...

Descripción completa

Detalles Bibliográficos
Autor principal: Naguy, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968506/
https://www.ncbi.nlm.nih.gov/pubmed/35433328
http://dx.doi.org/10.5498/wjp.v12.i3.533
_version_ 1784679059735707648
author Naguy, Ahmed
author_facet Naguy, Ahmed
author_sort Naguy, Ahmed
collection PubMed
description Adjunctive melatonin use in schizophrenia, as supported by a modicum of evidence, has multiple transcending chronobiotic actions, including fixing concurrent sleep problems to bona fide augmentative antipsychotic actions, mitigating the risk of tardive dyskinesias, curbing the drastic metabolic syndrome and ultimately providing neuroprotective actions. Its use is rather an art than science!
format Online
Article
Text
id pubmed-8968506
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-89685062022-04-14 Therapeutic use of melatonin in schizophrenia-more than meets the eye! Naguy, Ahmed World J Psychiatry Letter to the Editor Adjunctive melatonin use in schizophrenia, as supported by a modicum of evidence, has multiple transcending chronobiotic actions, including fixing concurrent sleep problems to bona fide augmentative antipsychotic actions, mitigating the risk of tardive dyskinesias, curbing the drastic metabolic syndrome and ultimately providing neuroprotective actions. Its use is rather an art than science! Baishideng Publishing Group Inc 2022-03-19 /pmc/articles/PMC8968506/ /pubmed/35433328 http://dx.doi.org/10.5498/wjp.v12.i3.533 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Naguy, Ahmed
Therapeutic use of melatonin in schizophrenia-more than meets the eye!
title Therapeutic use of melatonin in schizophrenia-more than meets the eye!
title_full Therapeutic use of melatonin in schizophrenia-more than meets the eye!
title_fullStr Therapeutic use of melatonin in schizophrenia-more than meets the eye!
title_full_unstemmed Therapeutic use of melatonin in schizophrenia-more than meets the eye!
title_short Therapeutic use of melatonin in schizophrenia-more than meets the eye!
title_sort therapeutic use of melatonin in schizophrenia-more than meets the eye!
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968506/
https://www.ncbi.nlm.nih.gov/pubmed/35433328
http://dx.doi.org/10.5498/wjp.v12.i3.533
work_keys_str_mv AT naguyahmed therapeuticuseofmelatonininschizophreniamorethanmeetstheeye

Ejemplares similares